News & Events
-
March 13, 2013
Kidney Injury Biomarkers Lipocalin-2, Clusterin and Albumin, but Not Kidney Injury Molecule 1, Are More Sensitive Than Traditional Markers of Gentamicin-Induced Kidney Injury in Beagles
Presenter – M Wagoner, L Cheatham, D Eisinger, F Sace, K M Lynch, J McDuffie, M Sonee, K Marshall, M Damour, L Stephen, Y P Dragan, J Fikes, L B Kinter Conference – Society of Toxicologists 2013 Annual Meeting -
March 13, 2013
Evaluation of an In Vitro Model of Spermatogenesis for Predicting Testicular Toxicity
Presenter – K M Goldstein, M Perrard, P Durand, T K Baker, D E Seyler Conference – Society of Toxicologists 2013 Annual Meeting -
March 12, 2013
Rapid Immunoassay Development and Evaluation of ICAM-1 and E-Selectin As Potential Biomarkers of Vascular Injury in Rats
Presenter – M Joseph Cameron, H W Smith, J L Weaver, N King, N Vansell, B E Enerson Conference – Society of Toxicologists 2013 Annual Meeting -
March 11, 2013
Circulating microRNAs As Biomarkers of Testicular Damage?
Presenter – R E Chapin Conference – Society of Toxicologists 2013 Annual Meeting -
March 7, 2013
Collaborating for Cures Leveraging Global Public-Private Partnerships to Accelerate Biopharmaceuticals Development
Event Date: 03/07/2013 The Innovative Medicines Initiative (IMI) and Critical Path Institute (C-Path) held a joint event in Brussels, Belgium on the challenges and opportunities of public-private partnerships (PPPs). More than 120 participants attended the conference and many more followed the live webcast. This first ever public conference co-sponsored by IMI and C-Path featured cross-sector...